BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6399432)

  • 1. [Advances in the treatment of lymphoblastic leukemia in children].
    Radwańska U
    Acta Haematol Pol; 1984; 15(3-4):203-11. PubMed ID: 6399432
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study on the treatment of acute lymphoblastic leukemia with T-cell markers in children].
    Nishikawa A; Saito K; Taniuchi S; Ohnishi T; Matsumura T
    Rinsho Ketsueki; 1984 May; 25(5):660-5. PubMed ID: 6332214
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute refractory lymphoblastic leukemia in the adult. Treatment with daunorubicin, cytosine arabinoside, 6-thioguanine, vincristine and prednisone].
    Marín P; Grañena A; Carreras E; Ribera JM; Rozman C
    Sangre (Barc); 1984; 29(6):987-92. PubMed ID: 6598237
    [No Abstract]   [Full Text] [Related]  

  • 4. Parotid mucoepidermoid carcinoma following chemotherapy for childhood acute lymphoblastic leukemia.
    Sandoval C; Jayabose S
    Pediatr Hematol Oncol; 2001; 18(3):217-20. PubMed ID: 11293291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of acute lymphoblastic leukemia in children: modified LSA2-L2 therapy].
    Ishii E; Hara T; Ueda K; Kishida K; Nakamura E; Miyazaki S; Yoshida N
    Rinsho Ketsueki; 1985 Apr; 26(4):487-93. PubMed ID: 3862888
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of acute lymphoblastic leukemia in childhood. Epicritical evaluation of 2 therapeutic regimes].
    Madon E; Cordero di Montezemolo L; Pastore G; Grazia G
    Minerva Pediatr; 1979 Jun; 31(12):909-14. PubMed ID: 288971
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combination treatment of acute leukemia in the child with dauno-rubidomycin].
    Sachtleben P; Binder H; Krämer D; Weyrich C; Chwartz W
    Dtsch Med Wochenschr; 1969 Sep; 94(39):1972-4 passim. PubMed ID: 5260586
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma protein fractions and alpha 1-acidglycoprotein as tumor markers in acute lymphoblastic leukemia.
    Abdalla A; Badrawy F; Khalifa A; Hamza R
    Chemioterapia; 1987 Jun; 6(2 Suppl):743-4. PubMed ID: 3509537
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination chemotherapy in relapsed childhood acute lymphoblastic leukemia.
    Amato KR; Sallan SE; Lipton JM
    Cancer Treat Rep; 1984 Feb; 68(2):411-2. PubMed ID: 6583001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-induced leukonychia.
    Benatti C; Gnocchi M; Travaglino E; Invernizzi R; Ascari E
    Haematologica; 2004 Jul; 89(7):EIM16. PubMed ID: 15257962
    [No Abstract]   [Full Text] [Related]  

  • 11. Intermediate dose methotrexate (IDM) in children with acute lymphocytic leukemia (ALL). An update.
    Freeman AI
    Sangre (Barc); 1985; 30(6):1007-33. PubMed ID: 3913034
    [No Abstract]   [Full Text] [Related]  

  • 12. Addition of rubidomycin to induction treatment with vincristine, prednisone, and L-asparaginase in standard-risk childhood acute lymphocytic leukemia (study ALL V): a report on behalf of the Dutch Childhood Leukemia Study Group.
    van der Does-van den Berg A; van Wering ER; de Koning J; Rammeloo JA; Solbu G; Suciu S; van Zanen GE
    Haematol Blood Transfus; 1987; 30():444-7. PubMed ID: 3305211
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk groups in a multicenter pilot study for treatment of acute lymphoblastic and acute undifferentiated leukemia in adults.
    Hoelzer D; Thiel E; Löffler H; Bodenstein H; Büchner T; Engelhardt R; Ganser A; Messerer D; Rühl H; Zwingers T
    Haematol Blood Transfus; 1985; 29():48-50. PubMed ID: 3861487
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].
    Skoczeń S; Balwierz W; Moryl-Bujakowska A; Pawińska K; Luszczyńska A; Balcerska A; Płoszyńska A; Chybicka A; Dobaczewski G; Juszczak K; Wachowiak J; Derwich K; Kowalczyk J; Wiśniewska-Slusarz H; Matysiak M; Krauze A; Pawelec K; Sońta-Jakimczyk D; Tomaszewska R; Wysocki M; Styczyńskii J; Swiatkiewicz V;
    Przegl Lek; 2006; 63(1):11-4. PubMed ID: 16892892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood acute lymphoblastic leukaemia: outcomes of 54 consecutive patients treated in Auckland 1985-1991.
    Mauger DC; Skeen JE
    N Z Med J; 1998 Nov; 111(1078):454-6. PubMed ID: 9891565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
    Paśnicki M
    Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current approaches to the treatment of lymphoblastic leukemia in children].
    Makhonova LA; Maiakova SA
    Pediatriia; 1980; (5):22-6. PubMed ID: 6930628
    [No Abstract]   [Full Text] [Related]  

  • 18. p53 expression and poor prognosis in childhood acute lymphoblastic leukemia.
    Hecker S; Sauerbrey A; Volm M
    Anticancer Res; 1994; 14(6B):2759-61. PubMed ID: 7872714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen.
    Poplack DG; Reaman GH; Wesley R
    Cancer Treat Rep; 1981; 65 Suppl 4():93-6. PubMed ID: 6955015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Present-day treatment of acute leukemia in children].
    Rumiantsev AG
    Pediatriia; 1980; (5):57-62. PubMed ID: 6930631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.